SBI Securities’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9K Sell
201
-18
-8% -$1.53K ﹤0.01% 1632
2026
Q1
$18.9K Sell
219
-118
-35% -$10.6K ﹤0.01% 1483
2025
Q4
$29.4K Buy
337
+167
+98% +$12.7K ﹤0.01% 1294
2025
Q3
$9.74K Buy
170
+7
+4% +$403 ﹤0.01% 1786
2025
Q2
$9.62K Hold
163
﹤0.01% 1724
2025
Q1
$11.9K Sell
163
-163
-50% -$13.5K ﹤0.01% 1538
2024
Q4
$27K Buy
+326
New +$25.7K ﹤0.01% 1220

Other funds holding GMED

SBI Securities's GMED Position: Q2 2026 in Review

SBI Securities reduced its Globus Medical (GMED) stake by 8.2% in Q2 2026, selling an estimated $1.53K and leaving 201 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

SBI Securities first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.4K in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • SBI Securities held 201 shares of Globus Medical worth $15.9K as of Q2 2026.
  • SBI Securities sold 18 Globus Medical shares in Q2 2026, an estimated $1.53K.
  • Globus Medical made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1632 holding.
  • SBI Securities first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Globus Medical position peaked at $29.4K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.